Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, whether he has held discussions with Bayer on the potential effects of Primodos.

Whilst the Medicines and Healthcare products Regulatory Agency (MHRA) has not had discussions with Bayer more broadly on the topic of Primodos and adverse effects in pregnancy, it has held discussions with Bayer on whether Bayer held scientific data for consideration by the Expert Working Group on Hormonal Pregnancy Tests. All data considered by the Group were published, and further discussions between MHRA and Bayer were therefore held to discuss whether the data required redaction of names or personal information prior to publication.